DK0871446T3 - Anvendelse af eliprodil til fremstilling af et lægemiddel til behandling af ischaemiske sygdomme i nethinden eller den optiske nerve - Google Patents
Anvendelse af eliprodil til fremstilling af et lægemiddel til behandling af ischaemiske sygdomme i nethinden eller den optiske nerveInfo
- Publication number
- DK0871446T3 DK0871446T3 DK96943986T DK96943986T DK0871446T3 DK 0871446 T3 DK0871446 T3 DK 0871446T3 DK 96943986 T DK96943986 T DK 96943986T DK 96943986 T DK96943986 T DK 96943986T DK 0871446 T3 DK0871446 T3 DK 0871446T3
- Authority
- DK
- Denmark
- Prior art keywords
- eliprodil
- retina
- optic nerve
- medicament
- manufacture
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US58200396A | 1996-01-02 | 1996-01-02 | |
| PCT/EP1996/005671 WO1997024123A1 (en) | 1996-01-02 | 1996-12-17 | Use of polyamine site antagonist for the manufacture of a medicament for the treatment of ischemic disorders of the eye |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0871446T3 true DK0871446T3 (da) | 2002-04-15 |
Family
ID=24327451
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK96943986T DK0871446T3 (da) | 1996-01-02 | 1996-12-17 | Anvendelse af eliprodil til fremstilling af et lægemiddel til behandling af ischaemiske sygdomme i nethinden eller den optiske nerve |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US6020352A (da) |
| EP (1) | EP0871446B1 (da) |
| JP (1) | JP2000507205A (da) |
| AT (1) | ATE214605T1 (da) |
| AU (1) | AU716670B2 (da) |
| CA (1) | CA2241913A1 (da) |
| DE (1) | DE69620027T2 (da) |
| DK (1) | DK0871446T3 (da) |
| ES (1) | ES2171233T3 (da) |
| HK (1) | HK1016068A1 (da) |
| PT (1) | PT871446E (da) |
| WO (1) | WO1997024123A1 (da) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9620350D0 (en) | 1996-09-30 | 1996-11-13 | Maudsley David J | Cancer vaccine |
| CN1324240A (zh) * | 1998-10-27 | 2001-11-28 | 阿尔康制药厂 | 外视网膜疾病的治疗 |
| US20030212107A1 (en) * | 2001-05-10 | 2003-11-13 | Kapin Michael A. | R-reliprodil for treating glaucoma |
| JP2007523202A (ja) * | 2004-02-24 | 2007-08-16 | ビオアクソン・テラプティーク・インコーポレーテッド | ４置換ピペリジン誘導体 |
| GB2432526A (en) * | 2005-11-24 | 2007-05-30 | Arakis Ltd | Use of ifenprodil for the treatment of ophthalmic diseases |
| US10149856B2 (en) | 2015-01-26 | 2018-12-11 | BioAxone BioSciences, Inc. | Treatment of cerebral cavernous malformations and cerebral aneurysms with rho kinase inhibitors |
| US10106525B2 (en) | 2015-01-26 | 2018-10-23 | BioAxone BioSciences, Inc. | Rho kinase inhibitor BA-1049 (R) and active metabolites thereof |
| US10857157B2 (en) | 2015-01-26 | 2020-12-08 | BioAxone BioSciences, Inc. | Treatment of cerebral cavernous malformations and cerebral aneurysms with rho kinase inhibitors |
| US11198680B2 (en) | 2016-12-21 | 2021-12-14 | BioAxone BioSciences, Inc. | Rho kinase inhibitor BA-1049 (R) and active metabolites thereof |
| US10537567B2 (en) | 2017-07-11 | 2020-01-21 | BioAxone BioSciences, Inc. | Kinase inhibitors for treatment of disease |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2534580A1 (fr) * | 1982-10-13 | 1984-04-20 | Synthelabo | Derives de phenyl-1 piperidino-2 propanol, leur preparation, et medicaments qui les contiennent |
| US5922773A (en) * | 1992-12-04 | 1999-07-13 | The Children's Medical Center Corp. | Glaucoma treatment |
-
1996
- 1996-12-17 JP JP9524002A patent/JP2000507205A/ja not_active Withdrawn
- 1996-12-17 WO PCT/EP1996/005671 patent/WO1997024123A1/en active IP Right Grant
- 1996-12-17 PT PT96943986T patent/PT871446E/pt unknown
- 1996-12-17 AT AT96943986T patent/ATE214605T1/de not_active IP Right Cessation
- 1996-12-17 AU AU13739/97A patent/AU716670B2/en not_active Ceased
- 1996-12-17 DK DK96943986T patent/DK0871446T3/da active
- 1996-12-17 ES ES96943986T patent/ES2171233T3/es not_active Expired - Lifetime
- 1996-12-17 DE DE69620027T patent/DE69620027T2/de not_active Expired - Fee Related
- 1996-12-17 EP EP96943986A patent/EP0871446B1/en not_active Expired - Lifetime
- 1996-12-17 CA CA002241913A patent/CA2241913A1/en not_active Abandoned
-
1997
- 1997-11-18 US US08/972,833 patent/US6020352A/en not_active Expired - Fee Related
-
1999
- 1999-03-16 HK HK99101082A patent/HK1016068A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| WO1997024123A1 (en) | 1997-07-10 |
| EP0871446B1 (en) | 2002-03-20 |
| CA2241913A1 (en) | 1997-07-10 |
| PT871446E (pt) | 2002-08-30 |
| ES2171233T3 (es) | 2002-09-01 |
| DE69620027T2 (de) | 2002-09-05 |
| US6020352A (en) | 2000-02-01 |
| AU716670B2 (en) | 2000-03-02 |
| JP2000507205A (ja) | 2000-06-13 |
| HK1016068A1 (en) | 1999-10-29 |
| ATE214605T1 (de) | 2002-04-15 |
| EP0871446A1 (en) | 1998-10-21 |
| AU1373997A (en) | 1997-07-28 |
| DE69620027D1 (de) | 2002-04-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE269846T1 (de) | N-substituierte aminotetraline als neuropeptid y y5 rezeptor-liganden und ihre anwendung zur behandlung von fettleibigkeit und anderen erkrankungen | |
| DK0725779T3 (da) | Hidtil ukendte (R)-5-Carbamoyl-8-fluor-3-N,N-disubstitueret-amino-3,4-dihydro-2H-1-benzopyraner | |
| NO990433L (no) | Nye forbindelser og blandinger for behandling av sykdommer i forbindelse med tryptase-aktivitet | |
| NO963850D0 (no) | Heterosykliske forbindelser, deres fremstilling og anvendelse | |
| DK0723444T3 (da) | Levobupivacain, som er egnet til behandling af kronisk smerte | |
| ATE288747T1 (de) | Methoden und zusammensetzungen zur modulierung der aktivität von alpha-adrenergen rezeptoren | |
| DE69814394D1 (de) | Verwendung von levobupivacain | |
| DK0556332T3 (da) | Substituerede tetrahydropyridiner og hydroxypiperidiner som midler til behandling af centralnervesystemet | |
| BR9908510A (pt) | Uso de um composto, composto, processo para a preparação de um composto, composição farmacêutica, e, processo de tratar um paciente que sofre de, ou em risco de, uma doença micobacteriana | |
| DK1110554T3 (da) | Medicinal præparater til behandling af öjensygdomme | |
| DK0871446T3 (da) | Anvendelse af eliprodil til fremstilling af et lægemiddel til behandling af ischaemiske sygdomme i nethinden eller den optiske nerve | |
| TR199700956T1 (xx) | Indazolkarboksamidler. | |
| TR200101149T2 (tr) | Dış retina bozukluklarının tedavisi. | |
| DK0637306T3 (da) | 4-Imidomethyl-1-[2'-phenyl-2'-oxoethyl]-piperidiner som serotonin-5HT2-antagonister, deres fremstilling og anvendelse til terapi | |
| HUP0000873A2 (hu) | A levobupivakain arcsebészeti alkalmazása | |
| DK0556322T3 (da) | Aminosulfonylurinstof-ACAT-inhibitorer | |
| HUP9700660A2 (hu) | Alfa1-adrenoreceptor antagonisták felhasználása a prosztata jóindulatú hyperpláziájának megelőzésére és kezelésére alkalmas gyógyszerkészítmények előállítására | |
| BG105962A (en) | Use of saredutant and the pharmaceutically acceptable salts thereof to produce medicaments used to treat or prevent mood disorders, adjustment disorders or mixed anxiety-depression disorders | |
| DK0799618T3 (da) | Anvendelse af alpha1-adrenoreceptor-antagonister i fremstillingen af et medikament til forebyggelsen og behandlingen af cancer | |
| DK1244438T3 (da) | Anvendelse af beta-adrenoceptorantagonister til fremstilling af et medikament til behandling af sygdomme i den ydre nethinde | |
| HUP0103712A2 (hu) | Paroxetin sók, eljárás az előállításukra és gyógyászati alkalmazásuk | |
| DE69510933D1 (de) | Amidderivate und ihre therapeutische anwendung | |
| TR199901385T2 (xx) | Piperidin t�revleri. | |
| HRP20080389A2 (en) | THE USE OF R(+)-α-(2,3-DIMETHOXYPHENYL)-1-[2-(4-FLUOROPHENYL)ETHYL]-4-PIPERIDINEMETHANOL FOR THE TREATMENT OF SLEEP DISORDERS | |
| FR2818147B1 (fr) | Nouvelle application therapeutique d'un derive de la thienyclyclohexylamine |